Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Somatropin, Atc H01ac01 For The Time 01.07.2025 - 30.06.2027 2025-11-15
Germany Completion Of A Non -exclusive Discount Agreement According To § 130a Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04aa33 For The Period 01.07.2025 - 30.06.2027 2025-11-15
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Golumumab, Atc L04ab06 For The Time 01.07.2025 - 30.06.2027 2025-11-15
Germany Open House Pharmaceutical Dact Treaties Sunatinib, Atc L01ex01 2025-11-15
Germany Open House Pharmaceutical Department Apremilast, Atc L04aa32 2025-11-15
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-11-15
Germany Open House Pharmaceutical Discounts On The Active Ingredient Enalapril, Atc C09aa02 2025-11-15
Germany Open House Pharmaceutical Discounts On The Active Ingredient Darifenacin, Atc G04bd10 2025-11-15
Germany Open House Medicinal Practice Treaties For The Active Ingredient Pegintereron Alfa-2a, Atc L03ab11 2025-11-15
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Umeclidinium Bromide, Atc R03bb07 2025-11-15
Whats app